Sponsor Pipeline

CStone Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
3
Recruiting
3
Phase 3
3
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT07622524
A Phase I Study of CS5007 in Participants With Advanced Solid Tumors		 Recruitment opened
Active Trials by Phase
Phase 3
3
Phase 2
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03789604 A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer Non Small Cell Lung Cancer Active, Not Recruiting
NCT05700448 Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal… Extranodal NK/T-cell Lymphoma Not Yet Recruiting
NCT04194775 A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma Active, Not Recruiting
Phase 2
NCT05297890 A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer Active, Not Recruiting
Phase 1/2
NCT06741644 A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors Advanced Solid Tumors Recruiting
Phase 1
NCT05279300 A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas Advanced Solid Tumor Recruiting
NCT07622524 A Phase I Study of CS5007 in Participants With Advanced Solid Tumors Advanced Solid Tumors Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Liver Cancer (1)
Get alerts when CStone Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free